SEC Form 4 · accession 0000899243-17-018067
Coherus Oncology, Inc. · CHRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan C. Herman
Officer — Chief Scientific Officer
Period of report
Jul 5, 2017
Accepted (ET)
Jul 7, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001512762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value | Jul 5, 2017 | S | 600 | $15.00 | D | 67,186 | D | |
| Common Stock, $0.0001 par valueF2 | holding | — | — | — | 300,164 | I | By Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.
- F2These shares are held by the Herman Trust, dated March 16, 2001, of which Reporting Person is a co trustee.